Foot and ankle bone identification
100 percent
- EndpointCT image series with correctly identified foot and ankle bones
- PopulationCT component test set
- Tested versionSMART Bun-Yo-Matic CT configuration submitted in K240642
FDA-cleared profile
Disior Ltd · CT/CTA · FDA-cleared (510(k))
Authorized purpose: Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.
Evidence takeaway. Evidence from the reviewed source record: FDA-described testing used 82 CT image series. Foot and ankle bones were correctly identified in all test series; metal presence detection was reported with 100% sensitivity and 98% specificity. The summary states that component testing met the predetermined acceptance criteria and that clinical data were not needed for the substantial-equivalence determination.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
100 percent
100 percent
98 percent
K240642
FDA submission evidence; component metrics are not diagnostic accuracy for a disease endpoint.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Price not public here; enter your quote
Not verified: Pricing information is recorded but not verified against a resolving source.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Eligible CT image series of the foot and ankle meeting labeled acquisition and quality requirements.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-08 · FDA K240642: SMART Bun-Yo-Matic CT
Source context, not route validation: The exact FDA summary establishes CT image-series processing and a software planning workflow; exact hosting and PACS or EHR interfaces require vendor confirmation.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-08 · FDA K240642: SMART Bun-Yo-Matic CT
Source context, not route validation: The exact FDA package describes SMART Bun-Yo-Matic CT as having a graphical user interface (GUI) to a web application. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "Interface (GUI) to a web application". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 · FDA K240642: SMART Bun-Yo-Matic CT
Source context, not route validation: Three-dimensional models, measurements, metal-detection results, and planning parameters for professional review.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-08 · FDA K240642: SMART Bun-Yo-Matic CT
Unresolved route: Three-dimensional models, measurements, metal-detection results, and planning parameters for professional review.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-08 · FDA K240642: SMART Bun-Yo-Matic CT
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Packet wording: "Interface (GUI) to a web application". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Paragon 28 publishes a current-family IFU describing foot and ankle measurement and surgical-planning workflows and their visualization-only boundaries.
product family · checked 2026-09-08Confirm exact-release availability, interfaces, hosting, security, support, and commercial terms during procurement.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor instructions for use, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public price or quote for the exact K240642 configuration was established in this review.
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
7 sources - 3 history items
Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment
Scope: regulatoryIdentity, modalityContext
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: productFamily, clinicalWorkflow, implementationCapabilities, limitations
Scope: postmarketSafety
Regulatory record
510(k)
Research record
fda record reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Disior Ltd
Authorized purpose: Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.
3D-Side SA
Customize supports adult total ankle arthroplasty planning with CT segmentation, 3D models, implant positioning and sizing, plan review, and X-ray-informed planning.
Agada Medical, Ltd.
Authorized purpose: Auto-Seg and Spine Auto-Seg accept spine and pelvis CT images and provide three-dimensional segmentation and labels to support spine-surgery planning and assessment by spine surgeons.
Brainomix Limited
Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history